Clinical Trial Update: Investigation of Genetic Determinants of Capecitabine Toxicity

View source ↗

Summary

This document reports a completed clinical trial investigating genetic determinants of capecitabine toxicity in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | Status: COMPLETED